ProCE Banner Activity

Integrating Emerging Targeted Therapies Into AML Treatment Strategies

Slideset Download
In this downloadable slideset, Roland B. Walter, MD, PhD, MS, examines FLT3, IDH1, and BCL2 inhibitors as well as other promising investigational treatments in clinical trial that may provide therapeutic advances for the management of patients with acute myeloid leukemia.

Released: December 13, 2017

Expiration: December 12, 2018

No longer available for credit.

Share

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

Supported by educational grants from

Astellas Text

Daiichi Sankyo, Inc.

Jazz Pharmaceuticals Inc

Pfizer, Inc.